10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001193125-18-326787`
Period End Date	20180930
Filing Date	20181114
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	slno-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 80 Cash Flow Statement 66

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	21.44M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.24M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.24M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.24M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	21.44M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$343.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$327.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$847.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$516.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$126.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$18.95M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$20.41M	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$466.00K	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$453.00K	USD	Point-in-time
Total assets	`Assets`	$30.84M	USD	Point-in-time
Total assets	`Assets`	$39.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$633.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$973.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.15M	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$127.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$110.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.73M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$5.08M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$5.67M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$13.00K	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$1.75M	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$225.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$16.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$13.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.21M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$19.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$21.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$141.48M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$140.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-113.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-117.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-124.56M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.82M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$30.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$39.02M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$946.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.99M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.05M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$26.00K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.19M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.69M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.56M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.90M	USD	3 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$589.00K	USD	3 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$228.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.97M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$10.77M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.63M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.88M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.77M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.63M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.97M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.88M	USD	1 Quarter
Cease-use income	`GainLossOnContractTermination`	$3.00K	USD	3 Qtrs
Cease-use income	`GainLossOnContractTermination`	$6.00K	USD	3 Qtrs
Cease-use income	`GainLossOnContractTermination`	$5.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$163.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$29.00K	USD	3 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-3.09M	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-3.25M	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$1.55M	USD	3 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-685.00K	USD	Annual
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.54M	USD	1 Quarter
Interest and other income (expense)	`OtherNonoperatingIncomeExpense`	$3.00K	USD	1 Quarter
Interest and other income (expense)	`OtherNonoperatingIncomeExpense`	$-595.00K	USD	3 Qtrs
Interest and other income (expense)	`OtherNonoperatingIncomeExpense`	$26.00K	USD	1 Quarter
Interest and other income (expense)	`OtherNonoperatingIncomeExpense`	$75.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.27M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$1.57M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.22M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$185.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-621.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.47M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$139.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.04M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.49M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-7.59M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-12.23M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.31M	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-1.09M	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-1.36M	USD	3 Qtrs
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-427.00K	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-2.84M	USD	3 Qtrs
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-208.00K	USD	1 Quarter
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-208.00K	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.29M	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.36M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.05M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-427.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.60M	USD	3 Qtrs
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.11	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.26	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.60	USD	3 Qtrs
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.94	USD	3 Qtrs
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.13	USD	1 Quarter
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.37	USD	3 Qtrs
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.07	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.31	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.71	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.54	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.67M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.44M	shares	3 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.11M	shares	3 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.43M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-13.60M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-10.64M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.29M	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.36M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.05M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-427.00K	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.49M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-7.59M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-12.23M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.31M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.47M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.03M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$731.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$749.00K	USD	3 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$195.00K	USD	3 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$197.00K	USD	3 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$163.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$29.00K	USD	3 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-3.09M	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-3.25M	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$1.55M	USD	3 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-685.00K	USD	Annual
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.54M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$589.00K	USD	3 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$228.00K	USD	1 Quarter
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$602.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-142.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-101.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$612.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$232.00K	USD	3 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$167.00K	USD	3 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-74.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-20.00K	USD	3 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.75M	USD	3 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.77M	USD	3 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.17M	USD	3 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-2.47M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.22M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.95M	USD	3 Qtrs
Costs of Essentialis acquisition paid	`PaymentsToAcquireAssetsInvestingActivities`	$573.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	3 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.00K	USD	3 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-577.00K	USD	3 Qtrs
Net cash provided by discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$716.00K	USD	3 Qtrs
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.00K	USD	3 Qtrs
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$139.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	3 Qtrs
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.00M	USD	3 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$1.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.52M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.43M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.92M	USD	3 Qtrs
Net increase in cash and cash equivalents included in current assets held for sale	`CashAndCashEquivalentsPeriodIncreaseDecreaseIncludedInCurrentAssetsHeldForSale`	$-468.00K	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.76M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.24M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.76M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.24M	USD	Point-in-time
Issuance of common stock in Essentialis acquisition	`StockIssued1`	$18.76M	USD	3 Qtrs
Contingent consideration of Essentialis acquisition	`NoncashOrPartNoncashAcquisitionContingentConsideration`	$1.09M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.